# Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases

> **NCT00278564** · PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 7 (actual)

## Conditions studied

- MYOPATHY

## Interventions

- **BIOLOGICAL:** Hematopoietic stem cell transplantation
- **DRUG:** Cyclophosphamide
- **DRUG:** Mesna
- **DRUG:** ATG(rabbit)
- **DRUG:** Methylprednisolone
- **DRUG:** G-CSF
- **DRUG:** Rituxan

## Key facts

- **NCT ID:** NCT00278564
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2016-07
- **Final completion:** 2016-07
- **Target enrollment:** 7 (ACTUAL)
- **Why stopped:** high relapse rate
- **Last updated:** 2018-08-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00278564

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00278564, "Stem Cell Transplantation in Idiopathic Inflammatory Myopathy Diseases". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT00278564. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*